Imogen Evans, Hazel Thornton, Ian Chalmers, Paul Glasziou. London, UK: Pinter & Martin Ltd, 2011. ISBN-13: 978-1-905-17748-6. Price: £6.99. Pages: 199 (paperback) Educating the layperson about treatments and how to judge what is useful can be a minefield. Having now been living in India for 6 months, I can see how easy it is to part with randomised controlled trials and research initiatives and depend on pharma for education in new therapies and medicines. I dread to think of the potential harm we could be doing to patients and the public by taking this approach. This book is an ideal follow-on from Ben Goldacre's highly acclaimed book Bad Science , and a good one to read before Goldacre's Bad Pharma . …
No takes yet. Share an insight, caveat, or question.
Neelima Deshpande (2013) studied this question.